sodium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate
$250.00
CAS No.: 129541-41-9
Catalog No.: 194859
Purity: 95%
MF: C14H12BrClNNaO7
MW: 444.597
Storage: 2-8 degree Celsius
SMILES: BrC=1C(=C2C(=CNC2=CC1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)[O-])O)O)O)Cl.[Na+]
Catalog No.: 194859
Purity: 95%
MF: C14H12BrClNNaO7
MW: 444.597
Storage: 2-8 degree Celsius
SMILES: BrC=1C(=C2C(=CNC2=CC1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)[O-])O)O)O)Cl.[Na+]
sodium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate; CAS No.: 129541-41-9; sodium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate. PROPERTIES: sodium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate is a crystalline solid. Its molecular formula is C12H13BrClNO7S {Na, and the molecular weight is approximately 482.64 g/mol. The compound has a melting point of approximately 150-152 C. It is moderately soluble in water and organic solvents such as methanol and dimethylformamide. For proper storage, it should be kept in a sealed container at room temperature, away from heat and direct sunlight. As a compound containing an indole ring, multiple hydroxyl groups, a carboxylate group, and halogen atoms, it may exhibit certain reactivity and stability. When handling it, protective gloves and eye protection should be worn. In case of accidental contact with skin or eyes, immediate rinsing with water is necessary. APPLICATIONS: In organic synthesis, this compound serves as a specialized intermediate. The hydroxyl groups can undergo reactions such as etherification and esterification. The carboxylate group can be converted to other functional groups. The indole ring and halogen atoms provide unique electronic effects. In the pharmaceutical industry, derivatives of this compound can be explored as potential drug candidates. For instance, in the development of certain antiviral drugs, the structure of sodium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate can be modified to enhance the drug's antiviral activity and pharmacokinetic properties (as reported in medicinal chemistry journals). Additionally, in the field of chemical research, it can be used as a starting material for the synthesis of novel organic compounds with potential applications in catalysis and sensing (as noted in organic chemistry research papers).
Reviews
Write Your Own Review